Predict your next investment

Roslin Technologies company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer


Unattributed | Alive

Total Raised


Last Raised

$12.4M | 4 yrs ago

About Roslin Technologies

Roslin Technologies is an animal agriculture technology company that has a band of core capabilities including genome sequencing, gene editing, transgenics, phenotyping, and bioinformatics that it offers as a service to clients but also uses to create sellable products. Its first suite of products revolves around a protein researchers have engineered in chicken eggs. This protein, which is produced in the eggs of genetically modified (transgenic) chickens, can help to regenerate livers. It has therapeutic applications in the pork industry - to prevent production losses in early weaned pigs by boosting their immune system - and also for animals and humans that have overused paracetamol, negatively impacting their liver function.

Roslin Technologies Headquarter Location

Sir Alexander Robertson Building Easter Bush Campus, Midlothian

Edinburgh, Scotland, EH25 9RG,

United Kingdom

+44 (0) 7590 83 0825

Latest Roslin Technologies News

Roslin pushes to commercialise stem cell tech

Jun 17, 2021

Menu Ernst van Orsouw BIOTECH FIRM Roslin Technologies has appointed a new chief executive with a specific remit to commercialise its 'cutting-edge' technologies – including stem cells for cultivated meat production and genomic breeding techniques. Roslin Technologies – which works closely with the Roslin Institute, home of the world-famous cloned sheep Dolly – has appointed Ernst van Orsouw, who was global director of strategy and marketing for Genus Ltd's Pig Improvement Company, to lead the company as it takes these techniques to market. Mr van Orsouw takes over from Roslin executive director and founder Glen Illing, as the company moves from developing technological innovations to deploying them through sales and partnership agreements. A short-term focus for the company will be securing commercial agreements from cultivated meat companies reportedly eager to use its growing portfolio of stem cell lines to 'ensure that the world can meet growing protein demands whilst protecting against the environmental impact of increased food production'. Mr van Orsouw said: “Roslin Technologies is the jewel in the crown of Scottish and British agribusiness, and I am excited to join at this stage in the company’s growth. Over the last few years, the company has built a world-class scientific platform that can fundamentally disrupt key areas of the AgTech industry. “The commercial potential of Roslin Technologies’ offerings can now be brought to market, from proprietary stem cell lines for cultivated meat and animal health, to genomic breeding programmes for insects and traditional livestock.” Chairman of the board of Roslin Technologies, Prof. Andy Porter, commented: “As a global company, we undertook an extensive worldwide search for the right person to lead the next exciting stage of growth. Ernst, with his deep understanding of the sector and multiple connections around the world, is ideally placed to enable Roslin Technologies to reach its undoubted potential as a global influencer; capable of matching food production levels needed to feed a global population with the critical requirement to achieve this goal, without placing undue burden on our precious natural environment. “With the academic backing of the Roslin Institute and the University of Edinburgh, we can now focus on commercialising the technologies we have developed, which will help shape the future-food ecosystem, and allow us to produce food in a responsible way.”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Roslin Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Roslin Technologies is included in 6 Expert Collections, including Genomics.



823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data


Agriculture Technology (AgTech)

1,669 items

Companies that are using technology to make farms more efficient.


Synthetic Biology

235 items

Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.


Animal Health Startups

193 items

Startups developing technology targeting health of livestock and aquaculture organisms


Industrial SynBio

67 items

Synthetic biology focused on replacing industrial and commercial materials.


Regenerative Medicine

1,763 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.